{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T06:54:05Z","timestamp":1760597645676},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,3,24]],"date-time":"2015-03-24T00:00:00Z","timestamp":1427155200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s00432-015-1962-x","type":"journal-article","created":{"date-parts":[[2015,3,23]],"date-time":"2015-03-23T08:03:43Z","timestamp":1427097823000},"page":"1661-1668","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Efficacy of antifungal prophylaxis with oral suspension posaconazole during induction chemotherapy of acute myeloid leukemia"],"prefix":"10.1007","volume":"141","author":[{"given":"Karin G.","family":"Schrenk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf","family":"Schnetzke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katy","family":"Stegemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"von Lilienfeld-Toal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Hochhaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Scholl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,24]]},"reference":[{"key":"1962_CR1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/leu.2008.352","volume":"23","author":"N Basara","year":"2009","unstructured":"Basara N, Schulze A, Wedding U, Mohren M, Gerhardt A, Junghanss C, Peter N, Dolken G, Becker C, Heyn S, Kliem C, Lange T, Krahl R, Ponisch W, Fricke HJ, Sayer HG, Al-Ali H, Kamprad F, Niederwieser D (2009) Early related or unrelated haematopoietic cell transplantation results in higher overall survival and leukaemia-free survival compared with conventional chemotherapy in high-risk acute myeloid leukaemia patients in first complete remission. Leukemia 23:635\u2013640","journal-title":"Leukemia"},{"key":"1962_CR2","doi-asserted-by":"crossref","unstructured":"Becker C, Ali HA, Krahl R, Poenisch W, Wedding U, Fiedler F, Pasold R, Freund M, Subert R, Kaempfe D, Meran J, Herold M, Peter N, Knauf W, Kettner E, Schultze W, Dachselt K, Wolf HH, Kreibich U, Schulze M, Ittel T, Assmann M, Grobe N, Huhn R, Steglich J, Schirmer V, Klinkenstein C, Opitz B, Winkelmann C, Haak U, Helbig W, Niederwieser D (2004) High complete remission rate in patients with acute myeloid leukemia (AML) above the age of 60 years: a report of the AML97#38 study of the East German Hematology and Oncology Study Group. ASH annual meeting Abstracts 104: 880","DOI":"10.1182\/blood.V104.11.880.880"},{"key":"1962_CR3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00277-013-1854-6","volume":"93","author":"H Bertz","year":"2014","unstructured":"Bertz H, Drognitz K, Lubbert M (2014) No difference between posaconazole and fluconazole antifungal prophylaxis and mycological diagnostics except costs in patients undergoing AML chemotherapy: a 1-year \u201creal-life\u201d evaluation. Ann Hematol 93:165\u2013167","journal-title":"Ann Hematol"},{"key":"1962_CR4","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/mmy\/myu042","volume":"52","author":"M Bourdelin","year":"2014","unstructured":"Bourdelin M, Grenouillet F, Daguindau E, Muret P, Desbrosses Y, Dubut J, Deconinck E, Limat S, Larosa F (2014) Posaconazole prophylaxis in neutropenic patients with hematological malignancies: limits in clinical practice. Med Mycol 52:728\u2013735","journal-title":"Med Mycol"},{"key":"1962_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000279442","volume":"127","author":"AR Brothman","year":"2009","unstructured":"Brothman AR, Persons DL, Shaffer LG (2009) Nomenclature evolution: changes in the ISCN from the 2005 to the 2009 edition. Cytogenet Genome Res 127:1\u20134","journal-title":"Cytogenet Genome Res"},{"key":"1962_CR6","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMoa061094","volume":"356","author":"OA Cornely","year":"2007","unstructured":"Cornely OA, Maertens J, Winston DJ, Perfect J, Ullmann AJ, Walsh TJ, Helfgott D, Holowiecki J, Stockelberg D, Goh YT, Petrini M, Hardalo C, Suresh R, Angulo-Gonzalez D (2007) Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 356:348\u2013359","journal-title":"N Engl J Med"},{"key":"1962_CR7","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B Pauw De","year":"2008","unstructured":"De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Munoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin Infect Dis 46:1813\u20131821","journal-title":"Clin Infect Dis"},{"key":"1962_CR8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2009-07-235358","volume":"115","author":"H Dohner","year":"2010","unstructured":"Dohner H, Estey EH, Amadori S, Appelbaum FR, Buchner T, Burnett AK, Dombret H, Fenaux P, Grimwade D, Larson RA, Lo-Coco F, Naoe T, Niederwieser D, Ossenkoppele GJ, Sanz MA, Sierra J, Tallman MS, Lowenberg B, Bloomfield CD (2010) Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 115:453\u2013474","journal-title":"Blood"},{"key":"1962_CR9","doi-asserted-by":"crossref","first-page":"5758","DOI":"10.1128\/AAC.03050-14","volume":"58","author":"RF Duarte","year":"2014","unstructured":"Duarte RF, Lopez-Jimenez J, Cornely OA, Laverdiere M, Helfgott D, Haider S, Chandrasekar P, Langston A, Perfect J, Ma L, van Iersel ML, Connelly N, Kartsonis N, Waskin H (2014a) Phase 1b study of new posaconazole tablet for prevention of invasive fungal infections in high-risk patients with neutropenia. Antimicrob Agents Chemother 58:5758\u20135765","journal-title":"Antimicrob Agents Chemother"},{"key":"1962_CR10","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1093\/cid\/ciu673","volume":"59","author":"RF Duarte","year":"2014","unstructured":"Duarte RF, Sanchez-Ortega I, Cuesta I, Arnan M, Patino B, Fernandez de Sevilla A, Gudiol C, Ayats J, Cuenca-Estrella M (2014b) Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxis. Clin Infect Dis 59:1696\u20131702","journal-title":"Clin Infect Dis"},{"key":"1962_CR11","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1513\/AnnalsATS.201304-097OC","volume":"10","author":"JB Garcia","year":"2013","unstructured":"Garcia JB, Lei X, Wierda W, Cortes JE, Dickey BF, Evans SE, Ost DE (2013) Pneumonia during remission induction chemotherapy in patients with acute leukemia. Ann Am Thorac Soc 10:432\u2013440","journal-title":"Ann Am Thorac Soc"},{"key":"1962_CR12","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3324\/haematol.2011.053058","volume":"97","author":"C Girmenia","year":"2012","unstructured":"Girmenia C, Frustaci AM, Gentile G, Minotti C, Cartoni C, Capria S, Trisolini SM, Matturro A, Loglisci G, Latagliata R, Breccia M, Meloni G, Alimena G, Foa R, Micozzi A (2012) Posaconazole prophylaxis during front-line chemotherapy of acute myeloid leukemia: a single-center, real-life experience. Haematologica 97:560\u2013567","journal-title":"Haematologica"},{"key":"1962_CR13","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s12032-009-9330-9","volume":"27","author":"A Gupta","year":"2010","unstructured":"Gupta A, Singh M, Singh H, Kumar L, Sharma A, Bakhshi S, Raina V, Thulkar S (2010) Infections in acute myeloid leukemia: an analysis of 382 febrile episodes. Med Oncol 27:1037\u20131045","journal-title":"Med Oncol"},{"key":"1962_CR14","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1200\/JCO.1999.17.3.796","volume":"17","author":"CP Heussel","year":"1999","unstructured":"Heussel CP, Kauczor HU, Heussel GE, Fischer B, Begrich M, Mildenberger P, Thelen M (1999) Pneumonia in febrile neutropenic patients and in bone marrow and blood stem-cell transplant recipients: use of high-resolution computed tomography. J Clin Oncol 17:796\u2013805","journal-title":"J Clin Oncol"},{"key":"1962_CR15","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1128\/AAC.01034-08","volume":"53","author":"G Krishna","year":"2009","unstructured":"Krishna G, Moton A, Ma L, Medlock MM, McLeod J (2009) Pharmacokinetics and absorption of posaconazole oral suspension under various gastric conditions in healthy volunteers. Antimicrob Agents Chemother 53:958\u2013966","journal-title":"Antimicrob Agents Chemother"},{"key":"1962_CR16","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/cam4.225","volume":"3","author":"HC Kung","year":"2014","unstructured":"Kung HC, Johnson MD, Drew RH, Saha-Chaudhuri P, Perfect JR (2014) Clinical effectiveness of posaconazole versus fluconazole as antifungal prophylaxis in hematology-oncology patients: a retrospective cohort study. Cancer Med 3:667\u2013673","journal-title":"Cancer Med"},{"issue":"11","key":"1962_CR17","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/1469-0691.12688","volume":"20","author":"N Lerolle","year":"2014","unstructured":"Lerolle N, Raffoux E, Socie G, Touratier S, Sauvageon H, Porcher R, Bretagne S, Bergeron A, Azoulay E, Molina JM, Lafaurie M (2014) Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study. Clin Microbiol Infect 20(11):952\u2013959","journal-title":"Clin Microbiol Infect"},{"key":"1962_CR18","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1128\/AAC.02686-13","volume":"58","author":"J Maertens","year":"2014","unstructured":"Maertens J, Cornely OA, Ullmann AJ, Heinz WJ, Krishna G, Patino H, Caceres M, Kartsonis N, Waskin H, Robertson MN (2014) Phase 1B study of the pharmacokinetics and safety of posaconazole intravenous solution in patients at risk for invasive fungal disease. Antimicrob Agents Chemother 58:3610\u20133617","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"1962_CR19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/annonc\/mdu192","volume":"26","author":"G Maschmeyer","year":"2015","unstructured":"Maschmeyer G, Carratal\u00e0 J, Buchheidt D, Hamprecht A, Heussel CP, Kahl C, Lorenz J, Neumann S, Rieger C, Ruhnke M, Salwender H, Schmidt-Hieber M, Azoulay E (2015) Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Oncol 26(1):21\u201333","journal-title":"Ann Oncol"},{"key":"1962_CR20","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s10096-011-1397-5","volume":"31","author":"M Michallet","year":"2012","unstructured":"Michallet M, Benet T, Sobh M, Kraghel S, El Hamri M, Cannas G, Nicolini FE, Labussiere H, Ducastelle S, Barraco F, Thomas X, Chelghoum Y, Nicolle MC, Bienvenu AL, Persat F, De Monbrison F, Picot S, Vanhems P (2012) Invasive aspergillosis: an important risk factor on the short- and long-term survival of acute myeloid leukemia (AML) patients. Eur J Clin Microbiol Infect Dis 31:991\u2013997","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1962_CR21","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00277-013-1698-0","volume":"92","author":"S Neumann","year":"2013","unstructured":"Neumann S, Krause SW, Maschmeyer G, Schiel X, von Lilienfeld-Toal M (2013) Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 92:433\u2013442","journal-title":"Ann Hematol"},{"key":"1962_CR22","first-page":"1068","volume":"91","author":"L Pagano","year":"2006","unstructured":"Pagano L, Caira M, Candoni A, Offidani M, Fianchi L, Martino B, Pastore D, Picardi M, Bonini A, Chierichini A, Fanci R, Caramatti C, Invernizzi R, Mattei D, Mitra ME, Melillo L, Aversa F, Van Lint MT, Falcucci P, Valentini CG, Girmenia C, Nosari A (2006) The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 91:1068\u20131075","journal-title":"Haematologica"},{"key":"1962_CR23","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3324\/haematol.2009.012054","volume":"95","author":"L Pagano","year":"2010","unstructured":"Pagano L, Caira M, Candoni A, Offidani M, Martino B, Specchia G, Pastore D, Stanzani M, Cattaneo C, Fanci R, Caramatti C, Rossini F, Luppi M, Potenza L, Ferrara F, Mitra ME, Fadda RM, Invernizzi R, Aloisi T, Picardi M, Bonini A, Vacca A, Chierichini A, Melillo L, de Waure C, Fianchi L, Riva M, Leone G, Aversa F, Nosari A (2010) Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study. Haematologica 95:644\u2013650","journal-title":"Haematologica"},{"key":"1962_CR24","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1093\/jac\/dku227","volume":"69","author":"L Pagano","year":"2014","unstructured":"Pagano L, Verga L, Busca A, Martino B, Mitra ME, Fanci R, Ballanti S, Picardi M, Castagnola C, Cattaneo C, Nadali G, Nosari A, Candoni A, Caira M, Salutari P, Lessi F, Aversa F, Tumbarello M (2014) Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey. J Antimicrob Chemother 69:3142\u20133147","journal-title":"J Antimicrob Chemother"},{"key":"1962_CR25","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/myc.12086","volume":"56","author":"L Peterson","year":"2013","unstructured":"Peterson L, Ostermann J, Rieger H, Ostermann H, Rieger CT (2013) Posaconazole prophylaxis\u2013impact on incidence of invasive fungal disease and antifungal treatment in haematological patients. Mycoses 56:651\u2013658","journal-title":"Mycoses"},{"key":"1962_CR26","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2165\/00003495-200868140-00002","volume":"68","author":"MJ Ruping","year":"2008","unstructured":"Ruping MJ, Vehreschild JJ, Cornely OA (2008) Patients at high risk of invasive fungal infections: when and how to treat. Drugs 68:1941\u20131962","journal-title":"Drugs"},{"key":"1962_CR27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/2047-783X-16-4-139","volume":"16","author":"M Sandherr","year":"2011","unstructured":"Sandherr M, Maschmeyer G (2011) Pharmacology and metabolism of voriconazole and Posaconazole in the treatment of invasive aspergillosis: review of the literature. Eur J Med Res 16:139\u2013144","journal-title":"Eur J Med Res"},{"key":"1962_CR28","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/1042819021000040297","volume":"44","author":"G Specchia","year":"2003","unstructured":"Specchia G, Pastore D, Carluccio P, Mele G, Montagna MT, Liso A, Rizzi R, Ianora AS, Liso V (2003) Pneumonia in acute leukemia patients during induction therapy: experience in a single institution. Leuk Lymphoma 44:97\u2013101","journal-title":"Leuk Lymphoma"},{"key":"1962_CR29","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s10096-010-0984-1","volume":"29","author":"H Syrjala","year":"2010","unstructured":"Syrjala H, Ohtonen P, Kinnunen U, Raty R, Elonen E, Nousiainen T, Jantunen E, Remes K, Itala-Remes M, Silvennoinen R, Koistinen P (2010) Blood stream infections during chemotherapy-induced neutropenia in adult patients with acute myeloid leukemia: treatment cycle matters. Eur J Clin Microbiol Infect Dis 29:1211\u20131218","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1962_CR30","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s00277-014-2108-y","volume":"93","author":"D Tacke","year":"2014","unstructured":"Tacke D, Buchheidt D, Karthaus M, Krause SW, Maschmeyer G, Neumann S, Ostermann H, Penack O, Rieger C, Ruhnke M, Sandherr M, Schweer KE, Ullmann AJ, Cornely OA (2014) Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology. Ann Hematol 93:1449\u20131456","journal-title":"Ann Hematol"},{"key":"1962_CR31","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S1473-3099(05)70297-8","volume":"5","author":"HA Torres","year":"2005","unstructured":"Torres HA, Hachem RY, Chemaly RF, Kontoyiannis DP, Raad II (2005) Posaconazole: a broad-spectrum triazole antifungal. Lancet Infect Dis 5:775\u2013785","journal-title":"Lancet Infect Dis"},{"key":"1962_CR32","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa061098","volume":"356","author":"AJ Ullmann","year":"2007","unstructured":"Ullmann AJ, Lipton JH, Vesole DH, Chandrasekar P, Langston A, Tarantolo SR, Greinix H, Morais de Azevedo W, Reddy V, Boparai N, Pedicone L, Patino H, Durrant S (2007) Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 356:335\u2013347","journal-title":"N Engl J Med"},{"key":"1962_CR33","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1093\/jac\/dkq121","volume":"65","author":"JJ Vehreschild","year":"2010","unstructured":"Vehreschild JJ, Ruping MJ, Wisplinghoff H, Farowski F, Steinbach A, Sims R, Stollorz A, Kreuzer KA, Hallek M, Bangard C, Cornely OA (2010) Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukaemia (AML): a 6\u00a0year experience of the Cologne AML cohort. J Antimicrob Chemother 65:1466\u20131471","journal-title":"J Antimicrob Chemother"},{"key":"1962_CR34","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1086\/508774","volume":"44","author":"TJ Walsh","year":"2007","unstructured":"Walsh TJ, Raad I, Patterson TF, Chandrasekar P, Donowitz GR, Graybill R, Greene RE, Hachem R, Hadley S, Herbrecht R, Langston A, Louie A, Ribaud P, Segal BH, Stevens DA, van Burik JA, White CS, Corcoran G, Gogate J, Krishna G, Pedicone L, Hardalo C, Perfect JR (2007) Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial. Clin Infect Dis 44:2\u201312","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-015-1962-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-015-1962-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-015-1962-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T02:58:11Z","timestamp":1598842691000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-015-1962-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,24]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["1962"],"URL":"https:\/\/doi.org\/10.1007\/s00432-015-1962-x","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,24]]}}}